About this trial
This proposal outlines the steps required for the creation of a pilot database of EEG recordings and de-identified medical records from patients internally referred within the UNMH Comprehensive Epilepsy Center. The UNMH EEG Corpus would be the first database of its kind. Other public databases contain either patient EEG signals or medical records, but without both kinds of information, it is impossible to relate pre-treatment neurobiomarkers with post-treatment prognosis. The database will also contain information that can improve seizure localization based off of scalp and intracranial EEG, and the requisite data for the creation of algorithms that forecast seizure activity; a development that could ultimately lead to novel responsive neural stimulation procedures that suppress seizures before they begin.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
We will screen with UNMH EEG database, Nihon Kohden Neuroworkbench first. After meeting all the inclusion and
Disqualifiers
18 years old or older. If the patient's age is over 89, we will aggregated them to age 90 or older so that the patient cannot be identified. Also, all the EEG data will be de-identified and only show the year of the study performed instead of the exact study date to reduce the risk of identification. Of note, we perform over few thousands of EEG studies per year and it will be almost impossible to identify the patient based on the study year.
Children under age of 18 years old will be excluded.
Mismatched patients between EEG database and EMR
Trial population
Patients of18 years old or older who has had EEG done at University of New Mexico with Nihon Kohden Neuroworkbench from 2007 till 2027.
Trial design
Case-control
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
UNMH EEG Corpus
Fully de-identified database creation matching between EEG and clinical data for adult patients of 18 years or older who underwent EEG study at UNMH from 2007 till 2027
Sponsors and contacts
Click on the lead sponsor to view all of their trials.